Your browser doesn't support javascript.
T cell and antibody functional correlates of severe COVID-19.
Yu, Krystle K Q; Fischinger, Stephanie; Smith, Malisa T; Atyeo, Caroline; Cizmeci, Deniz; Wolf, Caitlin R; Layton, Erik D; Logue, Jennifer K; Aguilar, Melissa S; Shuey, Kiel; Loos, Carolin; Yu, Jingyou; Franko, Nicholas; Choi, Robert Y; Wald, Anna; Barouch, Dan H; Koelle, David M; Lauffenburger, Douglas; Chu, Helen Y; Alter, Galit; Seshadri, Chetan.
  • Yu KKQ; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Fischinger S; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Smith MT; PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.
  • Atyeo C; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Cizmeci D; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Wolf CR; PhD program in Virology, Division of Medical Sciences, Harvard University, Boston, MA, USA.
  • Layton ED; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Logue JK; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Aguilar MS; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Shuey K; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Loos C; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Yu J; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Franko N; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Choi RY; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA.
  • Wald A; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Koelle DM; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Lauffenburger D; Providence Medical Group, Everett, WA, USA.
  • Chu HY; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Alter G; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.
  • Seshadri C; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, USA.
medRxiv ; 2020 Nov 30.
Article in English | MEDLINE | ID: covidwho-955709
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Comorbid medical illnesses, such as obesity and diabetes, are associated with more severe COVID-19, hospitalization, and death. However, the role of the immune system in mediating these clinical outcomes has not been determined. We used multi-parameter flow cytometry and systems serology to comprehensively profile the functions of T cells and antibodies targeting spike, nucleocapsid, and envelope proteins in a convalescent cohort of COVID-19 subjects who were either hospitalized (n=20) or not hospitalized (n=40). To avoid confounding, subjects were matched by age, sex, ethnicity, and date of symptom onset. Surprisingly, we found that the magnitude and functional breadth of virus-specific CD4 T cell and antibody responses were consistently higher among hospitalized subjects, particularly those with medical comorbidities. However, an integrated analysis identified more coordination between polyfunctional CD4 T-cells and antibodies targeting the S1 domain of spike among subjects that were not hospitalized. These data reveal a functionally diverse and coordinated response between T cells and antibodies targeting SARS-CoV-2 which is reduced in the presence of comorbid illnesses that are known risk factors for severe COVID-19. Our data suggest that isolated measurements of the magnitudes of spike-specific immune responses are likely insufficient to anticipate vaccine efficacy in high-risk populations.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: 2020.11.25.20235150

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Year: 2020 Document Type: Article Affiliation country: 2020.11.25.20235150